One in five children suffers from atopic eczema (the type related to allergies). For half of those children, the skin condition will last for life. Eczema, while not life-threatening or contagious, can cause serious discomfort, especially in younger years, with common symptoms including itchy and dry skin and, when bacteria are involved, weeping wounds that can lead to infections.
A new vaccine could soon prevent it from happening, however. Researchers from Trinity College Dublin have identified how flare-ups of bacteria-driven eczema impact the immune system. A vaccine could bolster the immune system and limit the severity of eczema, as well as reduce the need for antibiotics. It may even treat other atopic diseases, such as hay fever and asthma.
Examining a total of 93 children aged from 0-16 years, researchers compared the immune responses of three groups: those with eczema with a skin infection, those with eczema without infection, and...
A new vaccine could soon prevent it from happening, however. Researchers from Trinity College Dublin have identified how flare-ups of bacteria-driven eczema impact the immune system. A vaccine could bolster the immune system and limit the severity of eczema, as well as reduce the need for antibiotics. It may even treat other atopic diseases, such as hay fever and asthma.
Examining a total of 93 children aged from 0-16 years, researchers compared the immune responses of three groups: those with eczema with a skin infection, those with eczema without infection, and...
You're reading a preview of
BBC Science Focus (Digital) - 1 Issue, June 2024